Director, US Payer & Value Marketing

Job Title

The Director, Payer & Value Marketing reports to the Sr Director, Head of US Payer, Value, and Access Strategy and is responsible for leading Kite's portfolio-level payer and value marketing strategy across the US cell therapy portfolio.

This role will lead the development, refinement, and execution of payer and value communication strategies, resources, and tools that support appropriate access to Kite's in-line and launch products. The Director will lead a team responsible for developing payer-facing value stories, evidence-based resources, unbranded and branded payer tools as appropriate, budget impact and economic resources, payer education materials, and product-specific tactics as needed.

This role will work closely with HEOR, Medical Affairs, Brand, Pricing & Contracting, Field Market Access, Strategic Account Management, Legal, Regulatory, Compliance, Government Affairs, Advocacy, and other stakeholders to ensure payer and value strategies are evidence-based, customer-relevant, compliant, and aligned with broader portfolio objectives.

This role operates at the portfolio level and is accountable for ensuring Kite has a consistent and compelling value strategy across payer and access stakeholders, while also enabling product-specific execution through direct reports and cross-functional partners. Kite is relocating its primary office from Santa Monica, CA to two locations in Southern California (Thousand Oaks, CA and El Segundo, CA) at the end of 2026.

This is a hybrid position with three days per week in office. Throughout the remainder of 2026, the position can be based in Santa Monica, CA, Foster City, CA, or Parsippany, NJ. Beginning in Jan 2027, Thousand Oaks, CA and El Segundo, CA will replace Santa Monica, CA.

Key Responsibilities

Payer and Value Strategy

• Lead development and ongoing refinement of Kite's US payer and value marketing strategy across CAR T and future cell therapies
• Define portfolio-level value communication priorities and ensure alignment with US Market Access, Brand, HEOR, Medical, and Commercial objectives
• Serve as a strategic advisor to US Market Access leadership on payer trends, evidence needs, access barriers, competitive dynamics, and value communication opportunities
• Ensure payer and value strategies support improved coverage, reimbursement, network access, and stakeholder understanding of CAR T and future cell therapies
• Partner with Pricing & Contracting, Field Market Access, and Strategic Account Management to ensure value strategy supports customer engagement and access objectives

Payer-facing Tools, Resources, and Content

• Oversee development, execution, training, and optimization of payer-facing tools and resources, including value stories, value propositions, budget impact models, cost calculators, economic models, payer presentations, and related resources
• Ensure payer resources are evidence-based, customer-relevant, compliant, and aligned with portfolio and product-specific objectives
• Lead PRC and review strategy for payer-facing materials in partnership with Legal, Regulatory, Compliance, Medical, and HEOR partners
• Oversee team members responsible for product-specific payer and value tactics as needed for in-line brands, launches, and lifecycle opportunities
• Partner with training teams to support field readiness and consistent pull-through of approved payer and value resources

Evidence Translation and HEOR Partnership

• Partner with HEOR and Medical Affairs to translate clinical, economic, humanistic, and real-world evidence into appropriate payer and access stakeholder resources
• Identify payer evidence gaps and collaborate with HEOR, Medical, Global Market Access, and New Product & Launch Planning to inform evidence planning
• Support development of value platforms and payer communication strategies that reflect evolving clinical data, economic evidence, competitive dynamics, and stakeholder needs
• Ensure payer insights inform evidence generation priorities for in-line products, launch assets, and future pipeline opportunities
• Provide input into payer-relevant endpoints, evidence needs, and value narrative considerations

Payer, Employer, and Access Stakeholder…